Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
2.270
+0.060 (2.71%)
May 20, 2025, 1:47 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Genetic Diagnostic Testing
895.48K
Log In
Log In
Log In
Genetic Diagnostic Testing Growth
69.00%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Germany
895.48K
Log In
Log In
Log In
Germany Growth
69.00%
Log In
Log In
Log In